Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer
Coleman, Robert L, Prof, Duska, Linda R, MD, Ramirez, Pedro T, Prof, Heymach, John V, MD, Kamat, Aparna A, MD, Modesitt, Susan C, MD, Schmeler, Kathleen M, MD, Iyer, Revathy B, Prof, Garcia, Michael E, RN, Miller, Debbie L, RN, Jackson, Edward F, Prof, Ng, Chaan S, Prof, Kundra, Vikas, MD, Jaffe, Robert, Prof, Sood, Anil K, Prof
Published in The lancet oncology (01.11.2011)
Published in The lancet oncology (01.11.2011)
Get full text
Journal Article